Biotech

All Articles

Biogen, UCB record phase 3 lupus gain after stopping working earlier trial

.Biogen and also UCB's bet one's bottom dollar improving right into stage 3 astride a failed researc...

Aptadir wishes brand-new RNA preventions can easily turn around difficult cancers

.Italian biotech Aptadir Rehabs has released along with the commitment that its pipeline of preclini...

Wave surfs DMD results to regulatory authorities' doors, sending stockpile

.Surge Lifestyle Sciences has met its goal in a Duchenne muscle dystrophy (DMD) research, placing it...

Sanofi picks brand new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, taking up t...

Achilles drops tissue therapy system, supports for cutbacks after missing 'business viability' objectives

.Achilles Therapies has shreded its own tactic. The English biotech is actually stopping work on its...

Aligos trumpets phase 2 MASH succeed, reducing liver fat around 46%

.Aligos Therapies is actually heralding a midstage succeed in metabolic-dysfunction connected steato...

Basilea scores $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job developing brand new antifungals has received a considerable boost from...

Capricor offers Europe liberties to late-stage DMD therapy for $35M

.Possessing already scooped up the united state legal rights to Capricor Therapies' late-stage Duche...

FDA scraps adcomm for Applied's rare ailment medication

.After dismissing the choice meeting for Applied Therapies' metabolic disorder medication govorestat...

Novo inks $600M NanoVation deal to examine genetic drugs ex-liver

.Novo Nordisk is continuing its own press right into genetic medications, consenting to compensate N...